Literature DB >> 1974444

Dopamine-1 and dopamine-2 mechanisms in the control of renal function.

R M Carey1, H M Siragy, N V Ragsdale, N L Howell, R A Felder, M J Peach, R L Chevalier.   

Abstract

Dopamine (DA), a catecholamine produced in the kidney, is a renal vasodilator and natriuretic substance, but its action at dopamine-1 (DA-1), dopamine-2 (DA-2) and alpha- and beta-adrenergic receptors limits its effectiveness as a heuristic tool and pharmacologic agent. We have studied the effects of highly selective DA-1 and DA-2 receptor agonists and antagonists in normal human subjects and experimental animals to determine the precise physiological role of renal dopamine at DA-1 and DA-2 receptors within the kidney. We studied fenoldopam, a selective DA-1 agonist, in normal human subjects in metabolic balances at high (300 mEq/day) and low (10 mEq/day) sodium (Na) intake. Selective DA-1 receptor stimulation during high Na intake resulted in renal vasodilation, natriuresis and diuresis in a sustained manner for 3 hours. The natriuresis was mediated by a reduction in Na reabsorption at both proximal and distal tubular sites. In contrast, during low Na intake, DA-1 receptor stimulation did not engender a natriuretic or diuretic response. Thus, sodium depletion may inhibit the function of renal tubular cells in response to DA-1 stimulation. DA-1 receptors are present in the medial layer of the renal vasculature, proximal tubule and cortical collecting duct; DA-2 receptors are localized to the glomerulus, the renal nerves surrounding renal blood vessels and possibly the renal vascular endothelium. We have performed studies in conscious dogs with indwelling renal arterial catheters to identify the physiological role of renal DA to DA-1 and DA-2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974444     DOI: 10.1093/ajh/3.6.59s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

2.  Intravenous fenoldopam for early acute kidney injury after liver transplantation.

Authors:  Gianni Biancofiore; Maria L Bindi; Mario Miccoli; Elisabetta Cerutti; Bruna Lavezzo; Laura Pucci; Massimo Bisà; Massimo Esposito; Luca Meacci; Roberto Mozzo; Chiara Stratta; Giuseppe Penno; Angelo Baggiani; Franco Filipponi
Journal:  J Anesth       Date:  2014-11-30       Impact factor: 2.078

Review 3.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

Review 4.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

5.  The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens.

Authors:  James Daniel Obray; Eun Young Jang; Anneke M Klomp; Christina A Small; Aaron P Richardson; Joshua J LeBaron; Jin Gyeom Lee; Jordan T Yorgason; Chae Ha Yang; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2022-02-01       Impact factor: 3.455

Review 6.  Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury.

Authors:  Annalisa Noce; Giulia Marrone; Valentina Rovella; Andrea Busca; Caterina Gola; Michele Ferrannini; Nicola Di Daniele
Journal:  Curr Pharm Biotechnol       Date:  2019       Impact factor: 2.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.